Do depressive patients with family history of dementia constitute a separate group? A case report study

International Journal of Psychiatry in Clinical Practice

Volumn 4, Issue 3, 2000, Pages 215-222

  Fountoulakis, Kostas N ^a   Fotiou, Fotis ^a   Iacovides, Apostolos ^a   Kaprinis, George ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Biological markers; Dementia; Depression; DST; Familial aggregation; Psychophysiology; SPECT

Indexed keywords

DEXAMETHASONE; DEXFENFLURAMINE;

ADULT; ALZHEIMER DISEASE; ARTICLE; BORDERLINE STATE; CLINICAL ARTICLE; DEMENTIA; DEPRESSION; DEXAMETHASONE SUPPRESSION TEST; ELECTROOCULOGRAM; ELECTRORETINOGRAM; EVOKED VISUAL RESPONSE; FAMILY HISTORY; FEMALE; HIGH RISK PATIENT; HUMAN; HYPERCORTISOLISM; MALE; MENTAL STRESS; ONSET AGE; PRIORITY JOURNAL; PROVOCATION TEST; PSYCHOMETRY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STATISTICAL ANALYSIS;

EID: 0033825780     PISSN: 13651501     EISSN: None     Source Type: Journal    
DOI: 10.1080/13651500050518109     Document Type: Article

References (96)

1. Aspects of community health care of the elderly
2. Geronto-psychiatric period-prevalence investigation in a geographically delimited population
3. The prevalence of vascular dementia in Europe: Facts and fragments from 1980-1990 studies
4. Prevalence of medically diagnosed dementia in a defined United States population: Rochester, Minnesota, Jan 1, 1975
5. A case control study of dementia of the Alzheimer type
6. The association between head trauma and Alzheimer's disease
7. Head injury as a risk factor for Alzheimer's disease
8. A community-based study of parental age at the birth of patients with dementia of Alzheimer's type
9. Alzheimer's disease and maternal age
10. A study of familial factors m Alzheimer's disease
11. A case control study of Alzheimer's disease in Austria
12. Clinical risk factors for Alzheimer's disease: A population-based case-control study
13. The prevalence of dementia and Alzheimer's disease in Shanghai, China: Impact of age, gender and education
14. Educational occupation as risk factors for dementia: A population-based case study
15. Season of birth in Alzheimer's disease
16. Alzheimer's disease: A study of epidemiological aspects
17. Clinical and epidemiological aspects of Alzheimer's disease with presenile onset: A case control study
18. A case control study of late onset probable Alzheimer's disease
19. The association between aluminum-containing products and Alzheimer's disease
20. A case control study of Alzheimer's disease
21. Alcohol and tobacco consumption as risk factors for Alzheimer's disease: A collaborative reanalysis of case control studies
22. The association between Alzheimer's disease and thyroid disease
23. Risk factors for clinically diagnosed Alzheimer's disease: A case control study in a Greek elderly population
24. Neural science-introduction and overview
25. The measurement of genetic aspects of depression
26. History of dementia and Parkinson's disease in 1st-degree relatives of patients with Alzheimer's disease
27. Risk factors for late onset Alzheimer's disease: A population-based, case-control study
28. Familial aggregation in Alzheimer's disease: Comparison of risk among relatives of early- and late-onset cases, and among male and female relatives in successive generations
29. A rating scale for depression
30. A structured interview guide for the Hamilton Depression Rating Scale
31. The assessment of anxiety states by rating
32. The global assessment of functioning scale (GAS). Reliability and validity in greece
33. Dominance, aggressiveness and dysthymic symptoms in Greek population
34. The measurement of genetic aspects of depression
35. The family history method: Whose psychiatric history is measured?
36. The reliability of the family history method for psychiatric diagnosis
37. Stress and psychiatry
38. Evidence in support of a photoreceptoral origin for the light-peak substance
39. Is dopamine involved in the generation of the light peak in the intact chicken eye?
40. Acute blockade of dopamine receptors with haloperido: A retinal model to study impairments of dopaminergic transmission
41. Dopamine influences the light peak in the perfused mammalian eye
42. New clinical test of retinal function based upon the standing potential of the eye
43. Changes produced by light in the standing potential of the human eye
44. Standard for clinical electro-oculography
45. Clinical electro-oculography
46. The Dexamethasone Suppression Test: A review
47. The Dexamethasone Suppression Test in depression
48. Pretreatment DST and hypothalamic-pituitary-adrenocortical function in depressed patients and comparison groups
49. Resistance of suppression by dexamethasone of plasma 11-OHCS levels in severe depressive illness
50. Further investigation of the Dexamethasone Suppression Test in affective illness: Relationship to clinical diagnosis and therapeutic response
51. Resistance to inhibiting effect of dexamethasone in patients with endogenous depression
52. The Dexamethasone Suppression Test: An overview of its current status in psychiatry
53. Plasma prolactin changes following fenfluramine in depressed patients compared to controls: An evaluation of central serotonergic responsivity in depression
54. Effect of midbrain raphe lesion or 5-7 dihydroxytryptamine treatment on the prolactin releasing action of quipazine and d-fenfluramine in rats
55. From fenfluramine racemate to d-fenfluramine: Specificity and potency of the effects on the serotoninergic system and food intake
56. Evidence that the medial and dorsal raphe nuclei mediate serotonergically-induced increases in prolactin release from the pituitary
57. Neurobiology of an anorectic drug: Fenfluramine
58. D- and L-isomers of fenfluramine differ markedly in their interaction with brain serotonin and catecholamines in the rat
59. Prolactin secretion in man: A useful tool to evaluate the activity of drugs on central 5-HT neurones. Studies with fenfluramine
60. Reduction of food intake by manipulation of central serotonin
61. Summary and conclusions
62. Pharmacological characterization of serotonin receptors involved in the control of prolactin secretion
63. Single photon emission computed tomography
64. The validity of DSM-III axis IV (severity of psychosocial stressors)
65. Bipolar I, bipolar II and non bipolar major depression among the relatives of affectively ill probands
66. Prevalence and incidence of Alzheimer's disease and other dementing disorders in Pylea, Greece
67. Risk factor for Alzheimer's disease: A case control study
68. Psychiatric history and related exposures as risk factors for Alzheimer's disease: A collaborative reanalysis of case-control studies. EURODEM Risk Factors Research Group
69. Senile plaques in the locus coeruleus of young depressives: Localization with an electron microscopical method
70. Transduction of psychosocial stress into the neurobiology of recurrent affective disorder
71. The effects of stress on memory and the hippocampus throughout the life cycle: Implications for childhood development and aging
72. Does stress damage the brain?
73. Hippocampal abnormalities in depression
74. Depression duration but not age predicts hippocampal volume loss in medically healthy women with recurrent major depression
75. Changes of brain anatomy in patients with posttraumatic stress disorder: A pilot magnetic resonance imaging study
76. A molecular and cellular theory of depression
77. Magnetic resonance imaging study of hippocampal volume in chronic combat-related posttraumatic stress disorder
78. Changes in the pupil reaction to light in melancholic patients
79. Does cognitive disorder affect antidepressant pharmacotherapy in geriatric depression?
80. Target symptoms for fluvoxamine in old age depression
81. Epidemiological dementia index (EDI): A screening instrument for dementia suitable for use in populations with low education level
82. The validation of epidemiological dementia index (EDI) in geriatric outpatients
83. Comparison of the diagnosis of melancholic and atypical features according to DSM-IV and somatic syndrome according to ICD-10 in patients suffering from major depression
84. Antidepressant specificity in atypical depression
85. Effects of iproniazid in depressive syndromes
86. Some newer drugs in the treatment of depression and their relation to other somatic treatments
87. Comparison of antidepressant drugs in depressive illnesses
88. Persistent high cortisol responses to repeated psychological stress in a subpopulation of healthy men
89. Temperament and hypercortisolemia in depression
90. Depressive behavior and hyperactive adrenocortical function
91. Fewer pigmented locus coeruleus neurons in suicide victims: Preliminary results